For instance, in WT1-mutated AML cells, using short hairpin RNA or pharmacological PRC2/EZH2 inhibitors was shown to promote myeloid differentiation (Sinha et al., 2015). This evidence concerns the gene EZH2 and acute myeloid leukemia.